LHX vs MGNX · P/E 34, rev $5.88B vs rev $39.6M
L3Harris Technologies Inc (LHX) versus MacroGenics Inc (MGNX) — a side-by-side from cached financials, not a winner call.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
LHX currently screens at market cap $58.72B and trailing P/E 34.3. MGNX currently screens at market cap $246.6M.
Not investment advice. Open the LHX and MGNX stock pages for the full models.
Not investment advice.